Home LiteratureArticle Details
PMID: 9389420 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

Diabetologia ·Vol. 40 ·No. 11 ·1997-11-00 ·Pages 1286-92

Pickup JC, Mattock MB, Chusney GD, Burt D

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) is commonly associated with hypertriglyceridaemia, low serum HDL-cholesterol concentrations, hypertension, obesity and accelerated atherosclerosis (metabolic syndrome X). Since a similar dyslipidaemia occurs with the acute-phase response, we investigated whether elevated acute-phase/stress reactants (the innate immune system's response to environmental stress) and their major cytokine mediator (interleukin-6, IL-6) are associated with NIDDM and syndrome X, and may thus provide a unifying pathophysiological mechanism for these conditions. Two groups of Caucasian subjects with NIDDM were studied. Those with any 4 or 5 features of syndrome X (n = 19) were compared with a group with 0 or 1 feature of syndrome X (n = 25) but similar age, sex distribution, diabetes duration, glycaemic control and diabetes treatment. Healthy non-diabetic subjects of comparable age and sex acted as controls. Overnight urinary albumin excretion rate, a risk factor for cardiovascular disease, was also assayed in subjects to assess its relationship to the acute-phase response. Serum sialic acid was confirmed as a marker of the acute-phase response since serum concentrations were significantly related to established acute-phase proteins such as alpha-1 acid glycoprotein (r = 0.82, p < 0.0001). There was a significant graded increase of serum sialic acid, alpha-1 acid glycoprotein, IL-6 and urinary albumin excretion rate amongst the three groups, with the lowest levels in non-diabetic subjects, intermediate levels in NIDDM patients without syndrome X and highest levels in NIDDM patients with syndrome X. C-reactive protein and cortisol levels were also higher in syndrome X-positive compared to X-negative patients and serum amyloid A was higher in both diabetic groups than in the control group. We conclude that NIDDM is associated with an elevated acute-phase response, particularly in those with features of syndrome X. Abnormalities of the innate immune system may be a contributor to the hypertriglyceridaemia, low HDL cholesterol, hypertension, glucose intolerance, insulin resistance and accelerated atherosclerosis of NIDDM. Microalbuminuria may be a component of the acute-phase response.

MeSH Terms
Acute-Phase Proteins/analysis Adult Albuminuria/urine C-Reactive Protein/analysis Diabetes Mellitus, Type 2/blood,immunology Female Humans Hydrocortisone/blood Insulin Resistance/immunology Interleukin-6/blood Male Middle Aged N-Acetylneuraminic Acid/blood Orosomucoid/analysis Serum Amyloid A Protein/analysis
Chemicals
Acute-Phase Proteins Interleukin-6 Orosomucoid Serum Amyloid A Protein C-Reactive Protein N-Acetylneuraminic Acid Hydrocortisone
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Pickup J C
Division of Chemical Pathology, UMDS, Guy's Hospital, London, UK.
Mattock M B
Chusney G D
Burt D
References (48)
48 references, click to expand
  1. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?
    Diabetes. 1994 May;43(5):613-21 PMID: 8168635
  2. Syndrome X: a syndrome of insulin resistance. Epidemiological and clinical evidence.
    Diabetes Metab Rev. 1994 Apr;10(1):19-29 PMID: 7956673
  3. Serum sialic acid enzymatic assay based on microtitre plates: application for measuring capillary serum sialic acid concentrations.
    Br J Biomed Sci. 1993 Jun;50(2):164-7 PMID: 8219921
  4. Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus.
    Ann Intern Med. 1992 Nov 15;117(10):807-11 PMID: 1416554
  5. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein.
    Immunol Today. 1994 Feb;15(2):81-8 PMID: 8155266
  6. Increased levels of acute-phase serum proteins in diabetes.
    Metabolism. 1989 Nov;38(11):1042-6 PMID: 2478861
  7. A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants.
    Kobe J Med Sci. 1981 Jun;27(3):91-102 PMID: 7021999
  8. Effect of patient age on tests of the acute-phase response.
    Arch Pathol Lab Med. 1993 Sep;117(9):906-10 PMID: 7690224
  9. Immunological mechanisms in atherosclerosis.
    J Intern Med. 1995 Dec;238(6):479-89 PMID: 9422033
  10. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins.
    J Lipid Res. 1989 Jan;30(1):39-49 PMID: 2493057
  11. Coronary heart disease in diabetes mellitus: three new risk factors and a unifying hypothesis.
    J Intern Med. 1995 Jul;238(1):21-30 PMID: 7608643
  12. Haematological stress syndrome in atherosclerosis.
    J Clin Pathol. 1981 May;34(5):464-7 PMID: 7251888
  13. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension.
    Arch Intern Med. 1989 Jul;149(7):1514-20 PMID: 2662932
  14. Influence of corticotropin-releasing factor on reproductive functions in the rat.
    Endocrinology. 1984 Mar;114(3):914-21 PMID: 6321146
  15. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin.
    Lab Invest. 1991 Jun;64(6):724-42 PMID: 1646350
  16. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling.
    Science. 1988 Jun 10;240(4858):1546-8 PMID: 3259727
  17. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.
    N Engl J Med. 1984 Feb 9;310(6):356-60 PMID: 6690964
  18. Role of cytokines in inducing hyperlipidemia.
    Diabetes. 1992 Oct;41 Suppl 2:97-101 PMID: 1526345
  19. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance.
    N Engl J Med. 1989 Mar 16;320(11):702-6 PMID: 2646537
  20. Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Thyroid Cell Group.
    Lymphokine Res. 1989 Fall;8(3):335-40 PMID: 2674559
  21. Plasma lipid alterations in leukemia and lymphoma.
    Am J Med. 1982 May;72(5):775-82 PMID: 7081275
  22. Tumor necrosis factor alpha: a key component of the obesity-diabetes link.
    Diabetes. 1994 Nov;43(11):1271-8 PMID: 7926300
  23. Serum sialic acid concentration and coronary heart disease in NIDDM.
    Diabetes Care. 1995 Aug;18(8):1100-3 PMID: 7587844
  24. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study.
    BMJ. 1996 Apr 27;312(7038):1061-5 PMID: 8616412
  25. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy.
    Diabetes Care. 1993 Jan;16(1):57-60 PMID: 8422833
  26. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes.
    Mol Cell Biol. 1992 Apr;12(4):1789-97 PMID: 1372389
  27. Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling.
    J Exp Med. 1993 Dec 1;178(6):2165-72 PMID: 8245789
  28. Blood glycoprotein levels in diabetes mellitus.
    Diabetologia. 1976 Jul;12(3):245-50 PMID: 60265
  29. Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus.
    Clin Chim Acta. 1993 Oct 15;219(1-2):131-8 PMID: 7508342
  30. Serum amyloid A (SAA), a protein without a function: some suggestions with reference to cholesterol metabolism.
    Med Hypotheses. 1991 Aug;35(4):337-41 PMID: 1943886
  31. Neuroendocrine regulation and obesity.
    Int J Obes Relat Metab Disord. 1992 Dec;16 Suppl 3:S73-9 PMID: 1338326
  32. Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients.
    Diabetologia. 1988 Feb;31(2):82-7 PMID: 3360225
  33. Increased cytokine production in mononuclear cells of healthy elderly people.
    Eur J Immunol. 1993 Sep;23(9):2375-8 PMID: 8370415
  34. The acute-phase response and associated lipoprotein abnormalities accompanying lymphoma.
    J Intern Med. 1993 Feb;233(2):201-4 PMID: 8433082
  35. Plasma C3d levels and ischemic heart disease in type II diabetes.
    Diabetes Care. 1993 Feb;16(2):445-9 PMID: 8432215
  36. Interleukin-6 in biology and medicine.
    Adv Immunol. 1993;54:1-78 PMID: 8379461
  37. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Diabetologia. 1993 Jul;36(7):642-7 PMID: 8359582
  38. Banting lecture 1988. Role of insulin resistance in human disease.
    Diabetes. 1988 Dec;37(12):1595-607 PMID: 3056758
  39. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.
    J Clin Invest. 1955 Sep;34(9):1345-53 PMID: 13252080
  40. Insulin modulation of acute-phase protein production in a human hepatoma cell line.
    Cytokine. 1991 Nov;3(6):619-26 PMID: 1724187
  41. AN IMMUNOASSAY METHOD FOR URINARY ALBUMIN AT LOW CONCENTRATIONS.
    Lancet. 1963 Nov 2;2(7314):913-4 PMID: 14052063
  42. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth.
    Diabetologia. 1993 Jan;36(1):62-7 PMID: 8436255
  43. Plasma sialic acid in animal models of diabetes mellitus: evidence for modulation of sialic acid concentrations by insulin deficiency.
    Life Sci. 1995;57(14):1383-91 PMID: 7564886
  44. Insulin, corticosterone and the autonomic nervous system in animal obesities: a viewpoint.
    Diabetologia. 1995 Aug;38(8):998-1002 PMID: 7589889
  45. Microalbuminuria predicts mortality in non-insulin-dependent diabetics.
    Diabet Med. 1984 May;1(1):17-9 PMID: 6242771
  46. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance.
    J Lipid Res. 1992 Dec;33(12):1765-76 PMID: 1479286
  47. The acute phase response.
    Immunol Today. 1994 Feb;15(2):74-80 PMID: 7512342
  48. Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes.
    Diabetes Care. 1992 Oct;15(10):1245-50 PMID: 1425083
Article Info
Journal
Diabetologia
Abbr.
Diabetologia
ISSN
0012-186X
Published
1997-11-00
Pages
1286-92
Language
English
Region
Germany
NLM ID
0006777
Subset
IM
Grants
Wellcome Trust · United Kingdom
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]